Literature DB >> 35251831

Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis in Resource-Limited Setting: A Case Report and Review of Literature.

Hitesh Gurjar1, Himani Singh2, Barkha Gurjar3.   

Abstract

We describe a case of a young male who presented with acute onset progressively worsening shortness of breath for four days duration. He used to smoke cigarettes, and his profession required prolonged periods of standing. He underwent a two-dimensional echocardiogram showing right ventricular (RV) strain and computed tomography (CT) showing thrombus in the left major pulmonary artery. His pulmonary embolism severity index (PESI) score was high, predicting higher short-term mortality. Treatment options including risks and benefits were discussed with the patient, and he underwent catheter-directed thrombolysis (CDT) with rapid resolution of symptoms, oxygen saturation, and pulmonary artery pressures (PAP). He was discharged home safely after successful treatment of his condition.
Copyright © 2022, Gurjar et al.

Entities:  

Keywords:  alteplase; catheter-directed thrombolysis; endovascular catheter-directed thrombolysis; resource-limited setting; submassive pulmonary embolism

Year:  2022        PMID: 35251831      PMCID: PMC8890591          DOI: 10.7759/cureus.21760

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

1.  Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter.

Authors:  T Schmitz-Rode; U Janssens; S H Duda; C M Erley; R W Günther
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

Authors:  S Z Goldhaber; L Visani; M De Rosa
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

3.  A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

Authors:  Gregory Piazza; Benjamin Hohlfelder; Michael R Jaff; Kenneth Ouriel; Tod C Engelhardt; Keith M Sterling; Noah J Jones; John C Gurley; Rohit Bhatheja; Robert J Kennedy; Nilesh Goswami; Kannan Natarajan; John Rundback; Immad R Sadiq; Stephen K Liu; Narinder Bhalla; M Laiq Raja; Barry S Weinstock; Jacob Cynamon; Fakhir F Elmasri; Mark J Garcia; Mark Kumar; Juan Ayerdi; Peter Soukas; William Kuo; Ping-Yu Liu; Samuel Z Goldhaber
Journal:  JACC Cardiovasc Interv       Date:  2015-08-24       Impact factor: 11.195

4.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

5.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

6.  Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.

Authors:  J A Kline; K E Nordenholz; D M Courtney; C Kabrhel; A E Jones; M T Rondina; D B Diercks; J R Klinger; J Hernandez
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

Review 7.  Catheter technique for pulmonary embolectomy or thrombofragmentation.

Authors:  K J Cho; N L Dasika
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

8.  Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.

Authors:  Nils Kucher; Peter Boekstegers; Oliver J Müller; Christian Kupatt; Jan Beyer-Westendorf; Thomas Heitzer; Ulrich Tebbe; Jan Horstkotte; Ralf Müller; Erwin Blessing; Martin Greif; Philipp Lange; Ralf-Thorsten Hoffmann; Sebastian Werth; Achim Barmeyer; Dirk Härtel; Henriette Grünwald; Klaus Empen; Iris Baumgartner
Journal:  Circulation       Date:  2013-11-13       Impact factor: 29.690

Review 9.  Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis.

Authors:  Ashraf Mostafa; Alexandros Briasoulis; Tesfaye Telila; Kevin Belgrave; Cindy Grines
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

10.  Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.

Authors:  Kim A Ma; Susan R Kahn; Arash Akaberi; Carole Dennie; Christopher Rush; John T Granton; David Anderson; Philip S Wells; Marc A Rodger; Susan Solymoss; Michael J Kovacs; Lawrence Rudski; Avi Shimony; Paul Hernandez; Shawn D Aaron; Elena Pena; Gad Abikhzer; Andrew M Hirsch
Journal:  Res Pract Thromb Haemost       Date:  2018-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.